Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan M Bass

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
The New England Journal of Medicine|March 26, 2010
Rifaximin treatment in hepatic encephalopathyNathan M Bass, Kevin D Mullen, Arun Sanyal, et al.
Hepatology (Baltimore, Md.)|April 26, 2012
Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up studyLauren N Bell, Jiangxia Wang, Sriya Muralidharan, et al.
The New England Journal of Medicine|April 30, 2010
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitisArun J Sanyal, Naga Chalasani, Kris V Kowdley, et al.
Hepatology (Baltimore, Md.)|July 22, 2010
Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver diseaseBrent A Neuschwander-Tetri, Jeanne M Clark, Nathan M Bass, et al.
Molecular Cell|August 23, 2011
SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndromeMatthew D Hirschey, Tadahiro Shimazu, Enxuan Jing, et al.
Hepatology (Baltimore, Md.)|July 13, 2013
Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathyDon C Rockey, John M Vierling, Parvez Mantry, et al.
Hepatology (Baltimore, Md.)|October 27, 2005
Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosisBurton Combes, Scott S Emerson, Nancy L Flye, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
The New England Journal of Medicine|March 26, 2010
Rifaximin treatment in hepatic encephalopathyNathan M Bass, Kevin D Mullen, Arun Sanyal, et al.
Hepatology (Baltimore, Md.)|April 26, 2012
Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up studyLauren N Bell, Jiangxia Wang, Sriya Muralidharan, et al.
The New England Journal of Medicine|April 30, 2010
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitisArun J Sanyal, Naga Chalasani, Kris V Kowdley, et al.
Hepatology (Baltimore, Md.)|July 22, 2010
Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver diseaseBrent A Neuschwander-Tetri, Jeanne M Clark, Nathan M Bass, et al.
Molecular Cell|August 23, 2011
SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndromeMatthew D Hirschey, Tadahiro Shimazu, Enxuan Jing, et al.
Hepatology (Baltimore, Md.)|July 13, 2013
Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathyDon C Rockey, John M Vierling, Parvez Mantry, et al.
Hepatology (Baltimore, Md.)|October 27, 2005
Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosisBurton Combes, Scott S Emerson, Nancy L Flye, et al.
Pageof 6